IL134597A0 - Therapy for staphylococcus aureus - Google Patents

Therapy for staphylococcus aureus

Info

Publication number: IL134597A0
Authority: IL; Israel
Prior art keywords: staphylococcus aureus; therapy; strains; strain; directed
Prior art date: 1997-08-22

Application number

IL13459798A

Other languages

English (en)

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-08-22

Filing date

1998-08-18

Publication date

2001-04-30

1998-08-18 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

2001-04-30 Publication of IL134597A0 publication Critical patent/IL134597A0/xx

Links

241000191967 Staphylococcus aureus Species 0.000 title abstract 3
238000002560 therapeutic procedure Methods 0.000 title 1
DQJCDTNMLBYVAY-ZXXIYAEKSA-N (2S,5R,10R,13R)-16-{[(2R,3S,4R,5R)-3-{[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-(ethylamino)-6-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy}-5-(4-aminobutyl)-10-carbamoyl-2,13-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazaheptadecan-1-oic acid Chemical compound NCCCC[C@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)CC[C@H](C(N)=O)NC(=O)[C@@H](C)NC(=O)C(C)O[C@@H]1[C@@H](NCC)C(O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@@H](CO)O1 DQJCDTNMLBYVAY-ZXXIYAEKSA-N 0.000 abstract 1
102000002068 Glycopeptides Human genes 0.000 abstract 1
108010015899 Glycopeptides Proteins 0.000 abstract 1
RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 abstract 1
208000015181 infectious disease Diseases 0.000 abstract 1
229960003085 meticillin Drugs 0.000 abstract 1
230000035945 sensitivity Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Organic Chemistry (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

IL13459798A 1997-08-22 1998-08-18 Therapy for staphylococcus aureus IL134597A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US5671297P	1997-08-22	1997-08-22
PCT/US1998/017138 WO1999010006A1 (fr)	1997-08-22	1998-08-18	Therapie contre le staphylocoque dore

Publications (1)

Publication Number	Publication Date
IL134597A0 true IL134597A0 (en)	2001-04-30

Family

ID=22006150

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL13459798A IL134597A0 (en)	1997-08-22	1998-08-18	Therapy for staphylococcus aureus
IL134597A IL134597A (en)	1997-08-22	2000-02-17	Use of an antibiotic compound for the preparation of a drug for the treatment of diseases that can be attributed to Staphylococcus aureus

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL134597A IL134597A (en)	1997-08-22	2000-02-17	Use of an antibiotic compound for the preparation of a drug for the treatment of diseases that can be attributed to Staphylococcus aureus

Country Status (23)

Country	Link
US (1)	US5994297A (fr)
EP (1)	EP0897725B1 (fr)
JP (1)	JP2001513573A (fr)
KR (1)	KR100589548B1 (fr)
CN (1)	CN1276728A (fr)
AT (1)	ATE278413T1 (fr)
AU (1)	AU747418B2 (fr)
BR (1)	BR9811917A (fr)
CA (1)	CA2301589A1 (fr)
CZ (1)	CZ299098B6 (fr)
DE (1)	DE69826795T2 (fr)
DK (1)	DK0897725T3 (fr)
EA (1)	EA002602B1 (fr)
ES (1)	ES2229454T3 (fr)
HU (1)	HU226593B1 (fr)
ID (1)	ID24908A (fr)
IL (2)	IL134597A0 (fr)
NO (1)	NO327042B1 (fr)
NZ (1)	NZ502762A (fr)
PT (1)	PT897725E (fr)
TR (1)	TR200000475T2 (fr)
UA (1)	UA59410C2 (fr)
WO (1)	WO1999010006A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ591525A (en)	2008-08-30	2014-03-28	Medicines Co	Methods of treatment of complicated skin and skin structure infections using single doses of oritavancin
CN101928331B (zh) *	2009-06-26	2014-05-28	上海来益生物药物研究开发中心有限责任公司	一种化合物及其应用
CA2904387C (fr)	2013-03-15	2021-12-07	Melinta Therapeutics, Inc.	Procedes de traitement d'infections chez des patients atteints de surpoids et d'obesite utilisant d'antibiotiques

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU703106B2 (en) *	1994-01-28	1999-03-18	Eli Lilly And Company	Glycopeptide antibiotic derivatives

1998
- 1998-07-15 US US09/116,025 patent/US5994297A/en not_active Expired - Fee Related
- 1998-08-18 AU AU89137/98A patent/AU747418B2/en not_active Ceased
- 1998-08-18 PT PT98306571T patent/PT897725E/pt unknown
- 1998-08-18 AT AT98306571T patent/ATE278413T1/de not_active IP Right Cessation
- 1998-08-18 ES ES98306571T patent/ES2229454T3/es not_active Expired - Lifetime
- 1998-08-18 BR BR9811917-6A patent/BR9811917A/pt not_active Application Discontinuation
- 1998-08-18 JP JP2000507395A patent/JP2001513573A/ja active Pending
- 1998-08-18 WO PCT/US1998/017138 patent/WO1999010006A1/fr not_active Ceased
- 1998-08-18 EA EA200000250A patent/EA002602B1/ru not_active IP Right Cessation
- 1998-08-18 TR TR2000/00475T patent/TR200000475T2/xx unknown
- 1998-08-18 DE DE69826795T patent/DE69826795T2/de not_active Expired - Fee Related
- 1998-08-18 UA UA2000021041A patent/UA59410C2/uk unknown
- 1998-08-18 CN CN98810295A patent/CN1276728A/zh active Pending
- 1998-08-18 EP EP98306571A patent/EP0897725B1/fr not_active Expired - Lifetime
- 1998-08-18 CZ CZ20000619A patent/CZ299098B6/cs not_active IP Right Cessation
- 1998-08-18 ID IDW20000332A patent/ID24908A/id unknown
- 1998-08-18 HU HU0002920A patent/HU226593B1/hu not_active IP Right Cessation
- 1998-08-18 DK DK98306571T patent/DK0897725T3/da active
- 1998-08-18 NZ NZ502762A patent/NZ502762A/en unknown
- 1998-08-18 CA CA002301589A patent/CA2301589A1/fr not_active Abandoned
- 1998-08-18 KR KR1020007001730A patent/KR100589548B1/ko not_active Expired - Fee Related
- 1998-08-18 IL IL13459798A patent/IL134597A0/xx active IP Right Grant
2000
- 2000-02-17 IL IL134597A patent/IL134597A/en not_active IP Right Cessation
- 2000-02-21 NO NO20000851A patent/NO327042B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
WO1999010006A1 (fr)	1999-03-04
EA002602B1 (ru)	2002-06-27
PT897725E (pt)	2004-12-31
DE69826795D1 (de)	2004-11-11
CZ2000619A3 (en)	2001-05-16
US5994297A (en)	1999-11-30
EP0897725A3 (fr)	2000-02-09
UA59410C2 (uk)	2003-09-15
JP2001513573A (ja)	2001-09-04
IL134597A (en)	2007-09-20
DK0897725T3 (da)	2004-12-13
HU226593B1 (en)	2009-04-28
NO20000851L (no)	2000-02-21
AU747418B2 (en)	2002-05-16
CN1276728A (zh)	2000-12-13
EP0897725A2 (fr)	1999-02-24
NZ502762A (en)	2001-10-26
BR9811917A (pt)	2000-08-15
AU8913798A (en)	1999-03-16
NO20000851D0 (no)	2000-02-21
ATE278413T1 (de)	2004-10-15
CZ299098B6 (cs)	2008-04-23
NO327042B1 (no)	2009-04-06
ES2229454T3 (es)	2005-04-16
EP0897725B1 (fr)	2004-10-06
HUP0002920A3 (en)	2001-12-28
ID24908A (id)	2000-08-31
KR100589548B1 (ko)	2006-06-15
CA2301589A1 (fr)	1999-03-04
HUP0002920A2 (hu)	2001-01-29
EA200000250A1 (ru)	2000-08-28
KR20010023108A (ko)	2001-03-26
DE69826795T2 (de)	2005-10-06
TR200000475T2 (tr)	2000-08-21

Legal Events

Date	Code	Title
2008-02-10	FF	Patent granted
2008-03-23	KB	Patent renewed
2008-12-29	KB	Patent renewed

Publication	Publication Date	Title
PA8432701A1 (es)	2003-02-14	Derivados triciclicos sustituidos con fenilamino.
HN2000000051A (es)	2001-02-02	Derivados heterociclicos utiles como agentes anticancerosos
DE69421639D1 (de)	1999-12-23	Aza-Zyklohexapeptide
IT1254564B (it)	1995-09-25	Anticoagulanti e processi per la loro preparazione
WO2003037259A3 (fr)	2003-10-09	Methodes de prevention ou de traitement d'infections bacteriennes ou mycosiques
AU2005099A (en)	1999-07-12	Methods and compositions for the treatment and prevention of (staphylococcus aureus) infections
ES2110401T3 (es)	1998-02-16	Antibioticos pentapeptidicos derivados de dalbaheptidos.
MX232591B (es)	2005-12-02	Procedimiento para tratar infecciones oculares con azitromicina
FI924424A0 (fi)	1992-10-01	Hjaertskyddande tokoferolanaloger.
TNSN04035A1 (fr)	2006-06-01	Azithromycine en dose unique
ES2136457T3 (es)	1999-11-16	Dimeros unidos covalentemente de antibioticos glucopeptidicos.
ES2140184T3 (es)	2000-02-16	Dimeros unidos covalentemente de antibioticos glicopeptidicos.
EA200100700A1 (ru)	2001-12-24	Гены и белки и их применение
EP1066045A4 (fr)	2001-05-16	Peptides derives de mammiferes pour le traitement des infections microbiennes
ATE278413T1 (de)	2004-10-15	Staphylococcus aureus therapie
FR2674539B1 (fr)	1993-05-21	Procede de preparation enzymatique de macrolactone.
EA200100701A1 (ru)	2001-12-24	Белки наружной поверхности, их гены и их применение
SE9001111D0 (sv)	1990-03-27	Supportive use
ECSP951463A (es)	1996-07-16	Compuestos biciclicos